HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)

believed to be deficient in Sanfilippo syndrome type B
Also Known As:
alpha-N-acetylglucosaminidase; NAGLU
Networked: 68 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. McCarty, Douglas M: 5 articles (12/2015 - 03/2009)
2. Fu, Haiyan: 5 articles (12/2015 - 03/2009)
3. Di Natale, Paola: 5 articles (01/2015 - 06/2002)
4. Sanberg, Paul R: 5 articles (01/2014 - 12/2003)
5. Willing, Alison E: 4 articles (01/2014 - 12/2003)
6. Di Domenico, Carmela: 4 articles (04/2010 - 06/2002)
7. Garbuzova-Davis, Svitlana: 4 articles (07/2009 - 12/2003)
8. Di Napoli, Daniele: 3 articles (01/2015 - 07/2009)
9. Heldermon, Coy D: 3 articles (09/2014 - 01/2007)
10. Villani, Guglielmo R D: 3 articles (07/2009 - 06/2002)

Related Diseases

1. Disease Progression
2. Mucopolysaccharidosis III (Sanfilippo Syndrome)
3. Brain Diseases (Brain Disorder)
4. Mucopolysaccharidoses
5. Lysosomal Storage Diseases (Lysosomal Storage Disease)

Related Drugs and Biologics

1. alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)
2. Retinaldehyde (Retinal)
3. Heparitin Sulfate (Heparan Sulfate)
4. Acetylglucosaminidase (NAGase)
5. Hexosaminidases (Hexosaminidase)
6. Enzymes
7. Lysergic Acid Diethylamide (LSD)
8. Glucosamine (Dona)
9. Acetyl Coenzyme A (Acetyl-CoA)
10. Calcium-Calmodulin-Dependent Protein Kinase Type 2